China
· Delayed Price · Currency is CNY Shandong Pharmaceutical Glass Co.Ltd Statistics
Total Valuation
Shandong Pharmaceutical Glass Co.Ltd has a market cap or net worth of CNY 16.64 billion. The enterprise value is 13.64 billion.
| Market Cap | 16.64B |
| Enterprise Value | 13.64B |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
| Earnings Date | Oct 24, 2024 |
| Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
Shandong Pharmaceutical Glass Co.Ltd has 663.61 million shares outstanding. The number of shares has increased by 4.49% in one year.
| Shares Outstanding | 663.61M |
| Shares Change (YoY) | +4.49% |
| Shares Change (QoQ) | -1.62% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 23.20% |
| Float | 534.11M |
Valuation Ratios
The trailing PE ratio is 19.22 and the forward PE ratio is 15.20. Shandong Pharmaceutical Glass Co.Ltd's PEG ratio is 0.80.
| PE Ratio | 19.22 |
| Forward PE | 15.20 |
| PS Ratio | 3.23 |
| PB Ratio | 2.15 |
| P/FCF Ratio | 25.92 |
| PEG Ratio | 0.80 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.35, with an EV/FCF ratio of 21.25.
| EV / Earnings | 15.76 |
| EV / Sales | 2.65 |
| EV / EBITDA | 10.35 |
| EV / EBIT | 14.13 |
| EV / FCF | 21.25 |
Financial Position
The company has a current ratio of 2.87
| Current Ratio | 2.87 |
| Quick Ratio | 2.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 14,786.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 794,961 |
| Profits Per Employee | 133,704 |
| Employee Count | 6,473 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.17% in the last 52 weeks. The beta is 0.44, so Shandong Pharmaceutical Glass Co.Ltd's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -4.17% |
| 50-Day Moving Average | 24.25 |
| 200-Day Moving Average | 26.22 |
| Relative Strength Index (RSI) | 57.54 |
| Average Volume (20 Days) | 7,656,530 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shandong Pharmaceutical Glass Co.Ltd had revenue of CNY 5.15 billion and earned 865.46 million in profits. Earnings per share was 1.31.
| Revenue | 5.15B |
| Gross Profit | 1.53B |
| Operating Income | 965.64M |
| Pretax Income | 1.03B |
| Net Income | 865.46M |
| EBITDA | 1.32B |
| EBIT | 965.64M |
| Earnings Per Share (EPS) | 1.31 |
Balance Sheet
| Cash & Cash Equivalents | 3.00B |
| Total Debt | n/a |
| Net Cash | 3.00B |
| Net Cash Per Share | 4.52 |
| Equity (Book Value) | 7.74B |
| Book Value Per Share | 11.67 |
| Working Capital | 3.89B |
Cash Flow
In the last 12 months, operating cash flow was 1.22 billion and capital expenditures -578.62 million, giving a free cash flow of 642.09 million.
| Operating Cash Flow | 1.22B |
| Capital Expenditures | -578.62M |
| Free Cash Flow | 642.09M |
| FCF Per Share | 0.97 |
Margins
Gross margin is 29.69%, with operating and profit margins of 18.77% and 16.82%.
| Gross Margin | 29.69% |
| Operating Margin | 18.77% |
| Pretax Margin | 20.07% |
| Profit Margin | 16.82% |
| EBITDA Margin | 25.60% |
| EBIT Margin | 18.77% |
| FCF Margin | 12.48% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 2.39%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 2.39% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.00% |
| Buyback Yield | -4.49% |
| Shareholder Yield | -2.09% |
| Earnings Yield | 5.20% |
| FCF Yield | 3.86% |
Stock Splits
The last stock split was on June 20, 2019. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 20, 2019 |
| Split Type | Forward |
| Split Ratio | 1.4 |